EPO Patents = 1

Forward Citations = 10

Loading Chart...

2 inventors (with patents filed for the assignee):

Xiaofang Wang (5 out of 7 patents)

Ren-He Xu (5 out of 5 patents)

Ren-He Xu (0 patent)

5 patents: Sort by Forward Citations

1. 10842826 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2020-11-24),

2. 10557122 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2020-02-11),

3. 10226488 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2019-03-12),

4. 9745551 - Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof (2017-08-29),

5. 9725698 - Trophoblast-derived mesenchymal stem cells (T-MSCs) produced from human embryonic stem cells, methods and uses thereof (2017-08-08),

Imstem Biotechnology, Inc. is a leading biotechnology company focused on developing innovative stem cell-based therapies for various medical conditions. With a team of experienced researchers and scientists, Imstem is dedicated to advancing the field of regenerative medicine and improving patient outcomes. Visit our website to learn more about our groundbreaking research and cutting-edge technologies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

5 Patents

#25 in Farmington, CT

#987 in Connecticut

#50,255 in US

Farmington, CT, United States of America

Imstem Biotechnology, Inc.

Forward Citations = 10

2 inventors:

Xiaofang Wang (5 out of 7 patents)

Ren-He Xu (5 out of 5 patents)

Ren-He Xu (0 patent)

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com